Search

Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease that is, by definition, progressive. Progression of IPF is reflected by a decline in lung function, worsening of dyspnea and exercise capacity, and deterioration in health-related quality of life. In the short term, the course of disease for an individual patient is impossible to predict. A period of relative stability in forced vital capacity (FVC) does not mean that FVC will remain stable in the near future. Frequent monitoring using multiple assessments, not limited to pulmonary function tests, is important to evaluate disease progression in individual patients and ensure that patients are offered appropriate care. Optimal management of IPF requires a multidimensional approach, including both pharmacological therapy to slow decline in lung function and supportive care to preserve patients' quality of life. © 2019 The Author(s)Published by S. Karger AG, Basel.

Patients with chronic obstructive pulmonary disease (COPD) are at risk of developing osteoporosis, as the COPD in itself as well as continued smoking and treatment with systemic corticosteroid all increase the risk of developing osteoporosis. Other risk factors for osteoporosis are low vitamin D levels, malnutrition and physical inactivity. All patients who have risk factors in the form of severe COPD, and all patients with COPD in active treatment with systemic corticosteroid and/or other risk factors should be examined with a DEXA-scan. Treatment of osteoporosis in patients with COPD does not differ from general recommendations.

Persons with alpha1-antitrypsin (A1AT) deficiency and chronic obstructive pulmonary disease (COPD) have been tested for the clinical value of regular intravenous infusion with A1AT in two small double-blind randomised controlled trials. The trials found a statistical significant reduction in the decrease of lung density measured by computed tomographies, but found no clinical nor statistical significant difference in respiratory symptoms, quality of life, lung function, use of medication, exacerbations, respiratory infections or survival. Based on the present evidence A1AT substitution therapy cannot be recommended.

The aim of this study was to use sound reflections in a flexible tube (flextube reflectometry) for identifying the predominant obstructive level of the upper airway in a series of patients referred to a sleep clinic. We also wished to study the relationship between the number of flextube narrowings per hour recording and the RDI (respiratory disturbance index = apnoeas and hypopneas per hour recording) by ResMed AutoSet (AS), which is a device based on nasal pressure variations. We performed sleep studies on 54 patients referred for snoring or OSA; 1) at home with AS; 2) in hospital using flextube reflectometry and AS simultaneously. The predominant obstructive level of the upper airway was retropalatal in 15 of the patients and retrolingual in 25 of the patients determined by flextube reflectometry. In 14 there was no predominant level of narrowing. We found a statistically significant correlation between the number of flextube narrowings per hour recording and the RDIs by the AS (Spearman's correlation coefficient r = 0.62, p < 0.001, n = 54). Flextube reflectometry may provide useful information regarding the level of obstructive predominance during obstructive events. The method also determines the frequency of respiratory disturbances and records snoring sound.

The objective of this study was to compare sound reflections in a flexible tube (flextube reflectometry) with pressure-catheter recordings (ApneaGraph) for identifying the predominant obstructive level of the upper airway during sleep. Seventeen males with suspected obstructive sleep apnoea syndrome (OSAS) were included in the study. The mean (standard deviation = SD) number of flextube narrowings per hour recording was 50.2 (20.4) and the mean (SD) RDI (respiratory disturbance index = apnoeas and hypopnoeas per hour recording) determined by the ApneaGraph was 45.7 (20.2). The mean difference (SD) between the number of flextube narrowings per hour recording and the RDIs determined by the ApneaGraph was not statistically significantly different from 0. There was no statistically significant correlation between the percentage of retropalatal narrowing of the total narrowing (retropalatal and retrolingual narrowing) measured by flextube reflectometry and the percentage of retropalatal ("upper") obstructive apnoeas and hypopnoeas of the total number ("upper", "intermediate" and "lower") measured by ApneaGraph (Spearman's correlation coefficient r = 0.24, p = 0.36, N = 17). In conclusion diverging results were found in flextube reflectometry studies and pressure-recordings performed on different nights regarding the level distribution of obstructions during sleep. Possible explanations of this discrepancy are discussed.

We describe the development of a clinical model of nasal congestion using a fixed dose histamine challenge in normals. The objective was to use histamine to induce a similar degree of nasal congestion as a natural common cold (from unpublished data of 250 cold sufferers) and thus establish a rapid screening system for decongestant drug effects. Sixtynine normal subjects were challenged with histamine diphosphate (300 micrograms/nostril) on 2 visits. Thirtytwo subjects were identified showing reproducible baseline values (

This document is the result of the work and discussion of the Standardization Committee on Acoustic Rhinometry and presents guidelines for quality control and optimal application of acoustic rhinometry at its present stage. It is suggested that: 1. A well-defined standard nose is used for testing and optimising the equipment (data for a standard nose is given in the paper). 2. Procedures for evaluation of accuracy and repeatability of the measurements in the standard nose are presented, and error limits are defined for the area-distance curve as a whole, for the minimum cross-sectional area and for the volume from 0-5 cm into the nose. 3. Publication of results should include the volume 0-5 cm into the nose (volume from 2-5 cm for mucosal changes) the minimum cross-sectional area or preferably the two first minima and the distances to those areas. 4. The operator should be trained, follow a standard operating procedure and the environmental conditions (temperature and noise) be controlled. 5. Attention should be given to the nosepiece and the coupling between the equipment and the nose to obtain correct position, and sufficient seal without disturbing the anatomy. 6. The manufacturer should give information about the performance of the equipment, calibration procedures and maintenance, hygiene, environmental and safety standards.

The aim of this study was to find variables which characterize nasal obstruction. Scores from the clinical history, anterior rhinoscopy and objective values from acoustic rhinometry were found of importance. In a randomly-selected adult population of 230 individuals, 14% had the subjective feeling of nasal obstruction. The variables of significant value to predict nasal obstruction were: (1) symptoms of hypersensitivity/allergy and infection; (2) anterior septal deviations; and (3) small anterior dimensions of the nasal cavity. A minimum cross-sectional area (MCA) equal to 0.50 cm2, a cross-sectional area at the piriform aperture of 0.70 cm2 and a large effect of decongestion at MCA were found to be the best variables to separate obstructed from normal noses. Also, differences between each side of the nose were found of predictive value. In conclusion, a nose at risk for nasal obstruction is one with symptoms of allergy, frequent infections, small dimensions anteriorly, large difference between both sides, and a large degree of swelling of the mucosa.

The influence of the maxillary sinuses in acoustic rhinometry (AR) has not been evaluated, and this is the aim of the present study. We examined six subjects with AR and magnetic resonance imaging (MRI) after nasal decongestion to compare the area-distance relationships determined by the two methods. From the MRI data we obtained copies of the nasal cavities with and without maxillary sinuses, which were made in plastic by a stereolithographic method. AR curves from models without maxillary sinuses differed from AR curves with sinuses included but were in agreement with MRI curves without inclusion of sinuses. A similar difference in AR was seen in two subjects before and after the nasal cavities were flushed with saline to fill up the maxillary sinuses. The measured volume in the first 50 mm of the nasal cavity models was unaffected by the sinuses, but the volume in the first 70 mm corresponding to the length of the nasal cavity septum was increased slightly but significantly (from 10.8 to 11.3 cm3; P = 0.05). The presence of maxillary sinuses increased the volume of the epipharynx (70-100 mm from the nostril) from 12.2 to 21.3 cm3 (P

Bilateral inferior turbinoplasty was performed in cases of chronic nasal obstruction, in which conservative treatment had failed. Forty-five patients without significant septal deviation and with chronic nasal obstruction were objectively evaluated by acoustic rhinometry (AR) before and 3-6 months after turbinoplasty, in order to assess the changes of the dimensions of the nasal cavity obtained. Mucosal turbinate hypertrophy (defined objectively by AR) was present in 76% of the cases. Satisfactory subjective nasal patency was achieved in 93% of patients. Turbinoplasty resulted in an increase of 22% at the minimum cross-sectional area, 37% at the cross-sectional area 3.3 cm from the nostrils, and 47% at the cross-sectional area 4.0 cm from the nostrils. The increase was not related to the subjective result of the operation. Tendency to crusting and to vasomotor symptoms were related to unsatisfactory results. No crusting or bleeding were observed.

Nasal patency shows spontaneous variations but is also influenced by exercise and allergic conditions. These variations have not been described in detail with regard to allergy.

The nose with normal feeling of nasal patency, and no gross structural changes has been described in 82 individuals by acoustic rhinometry. Curves for one and both sides of the nasal cavity and before and after decongestion have been recorded. We have found that the minimal cross-sectional area (MCA) is located anteriorly in the nasal cavity; in some subjects it is localized at the head of the inferior turbinate and in other subjects more anteriorly at the nasal valve. After decongestion MCA moves even more anteriorly. Beyond the MCA the dimension of the nasal cavity increases, with maximal effect of decongestion at 4 cm from nostrils. Decongestion increases the total volume of the nasal cavity by 35%.

Ten healthy subjects (four men and six women) were subjected to localized skin cooling by submersion for 5 min of both feet and, in another experiment, one hand and forearm into ice-cold water. Repeated measurements of nasal cavity volumes by a new method, acoustic rhinometry, showed characteristic patterns ranging from marked increases in volumes lasting the entire exposure period to transient monophasic or biphasic responses to no change at all. The pattern in individual subjects was reproducible with the two methods of cooling, and it could be characterized by five types when related to baseline measurements during the preexposure period. Because of large minute-to-minute variations, probably determined by local differences and fluctuations in blood flow in tissues through the nose, evaluation of induced changes in the nasal cavity volume cannot be based on single measurements as has frequently been done in the past by using rhinomanometry as the experimental method. The mechanisms behind the characteristic patterns in immediate human nasal response to local skin cooling challenge remains to be explored.